Search results

This article is over 5 years old, and the information may therefore be outdated. Congratulations to Marcella Birtele who has succefully defended her thesis entitled “Functional and Transcriptional Studies of Human Dopaminergic Neurons” (October 2nd, 2020). For an interview with Marcella please click on the following link: https://www.regenerative-neurobiology.lu.se/article/thesis-defence-interview

https://www.regenerative-neurobiology.lu.se/article/congratulations-dr-birtele - 2026-07-09

This article is over 5 years old, and the information may therefore be outdated. Congratulations to Shelby Shrigley on nailing her thesis "Exploring Patient-Specific Cell Replacement Therapy for Parkinson's disease". The nailing took place on Friday, Feb 19th, 2021 and the defence will take place on Friday, March 12th, 2021.

https://www.regenerative-neurobiology.lu.se/article/nailing-shelby-shrigleys-thesis-successful - 2026-07-09

This article is over 5 years old, and the information may therefore be outdated. Congratulations to Prof. Malin Parmar, who has been elected as one of three new members of the Board of Directors at the International Society for Stem Cell Research (ISSCR). For full article please click here:  https://www.stemcellcenter.lu.se/article/malin-parmar-elected-isscr-board-directors  

https://www.regenerative-neurobiology.lu.se/article/malin-parmar-elected-isscr-board-directors - 2026-07-09

This article is over 5 years old, and the information may therefore be outdated. During her PhD studies Shelby Shrigley has been exploring patient-specific cell replacement therapy for Parkinson's disease. Defending her PhD thesis on March 12th, here Shelby tells us about her research within the Developmental and Regenerative Neurobiology research group led by Prof. Malin Parmar and her time spent

https://www.regenerative-neurobiology.lu.se/article/phd-defence-interview-shelby-shrigley-0 - 2026-07-09

This article is over 5 years old, and the information may therefore be outdated. We are very happy to congratulate Shelby Shrigley who on March 12th, 2021 successfully defended her thesis "Exploring Patient-Specific Cell Replacement Therapy for Parkinson's Disease"! To read Shelby's thesis "Exploring Patient-Specific Cell Replacement Therapy for Parkinson's Disease" OPEN ACCESS, please click here.

https://www.regenerative-neurobiology.lu.se/article/congratulations-dr-shrigley - 2026-07-09

Vinnova is Sweden's innovation agency with the mission to build Sweden’s innovation capacity. Earlier this year they announced a call for projects aiming to establish “Innovative environments for precision medicine” and last week they announced that the Lund-based project IndiCell is one of the funded projects. IndiCell is a collaborative project designed to connect academia, hospitals and industr

https://www.regenerative-neurobiology.lu.se/article/malin-parmar-anna-falk-awarded-5-year-grant-vinnova - 2026-07-09

We are very happy and proud to announce that Malin Parmar has been awarded a 10-year Distinguished professor grant from the Swedish Research Council! The aim of the distinguished professor programme is to create conditions for the most prominent researchers to conduct long-term, ground-breaking research with great potential for achieving scientific breakthroughs. The grant shall also enable the es

https://www.regenerative-neurobiology.lu.se/article/malin-parmar-awarded-distinguished-professor-grant-within-medicine-and-health - 2026-07-09

Läs här om ett samarbete mellan lundaforskarna Johan Jakobsson och Malin Parmar som har lett till en ny metod för att studera åldersrelaterade hjärnsjukdomar. https://www.lu.se/artikel/ny-forskningsmodell-ska-ge-svar-om-huntingtons-sjukdom  

https://www.regenerative-neurobiology.lu.se/article/ny-forskningsmodell-ska-ge-svar-om-huntingtons-sjukdom - 2026-07-09

Nya ledamöter studerar Parkinsons sjukdom / New members of the class for medical sciences. For more inforamtion please click on the below links: På Svenska: https://www.kva.se/nyheter/nya-ledamoter-studerar-parkinsons-sjukdom/ Lunds universitet: https://www.medicin.lu.se/artikel/lundaprofessor-invald-i-kungliga-vetenskapsakademien In English: https://www.kva.se/en/news/new-members-of-the-class-for

https://www.regenerative-neurobiology.lu.se/article/malin-parmar-becomes-new-member-royal-swedish-academy-sciences - 2026-07-09

What does your work consist of? As a coordinator, I have an overarching perspective since I work with all the faculty’s programmes. My job is partly to coordinating all written exams in the QPS system, and optimise the processes around this, and partly to provide training and support to the faculty's teachers and administrators. Currently I am focused on the written exams, but further on I will wo

https://www.qps.education.lu.se/en/article/frida-reisdal-exam-coordinator-faculty-medicine - 2026-07-09

Through her work, Professor Cenci Nilsson has developed preclinical models mimicking the symptoms of Parkinson’s disease and L-DOPA-induced dyskinesia, exploiting these models to discover disease mechanisms and new therapeutic approaches. With this motivation, MultiPark’s coordinator was awarded the 2022 Bengt Falck Prize in Neuroscience. In this extensive interview, Angela Cenci Nilsson shares he

https://www.multipark.lu.se/article/multiparks-coordinator-awarded-bengt-falck-prize-neuroscience - 2026-07-09

Imaging methods are valuable tools for understanding neurodegenerative diseases and monitoring the therapeutic effects of new treatments. That is why MultiPark researchers with expertise in clinical imaging gather across research groups. Clinical imaging methods is a new special interest group (SIG) addressing scientific and technological needs to apply these methods in research. Nicola Spotorno t

https://www.multipark.lu.se/article/clinical-imaging-methods-special-interest-group - 2026-07-09

People with Parkinson´s disease (PD) often develop abnormal involuntary movements (dyskinesias) during the course of their treatment with dopaminomimetic drugs.  In this new collaborative project, Angela Cenci Nilsson (Lund), Mattias Rickhag (Copenhagen) and Gilad Silberberg (Stockholm) will unravel the connections between dyskinesia and changes in the way the cerebral cortex and the striatum proc

https://www.multipark.lu.se/article/new-collaborative-project-tackles-previously-unknown-mechanisms-parkinsons-dyskinesias - 2026-07-09

Martino Avallone spent the past four years developing tools for mapping gene expression and proteins in the brain to investigate basic biological questions and to elucidate the molecular mysteries contributing to Parkinson’s disease. On 29 September, he defends his thesis work done in the Molecular Neuromodulation research group. Here, he explains the impact these tools will hopefully have in scie

https://www.multipark.lu.se/article/genetic-tools-studying-parkinsons-disease-phd-interview-martino-avallone - 2026-07-09

Megg Garcia-Ryde’s thesis sheds light on the early pathological processes in Alzheimer’s disease and the interplay between neurons and microglia as the disease evolves. October 10, she defends her thesis. Now, she gives her perspectives from a close collaboration between two of MultiPark’s experimental research groups and how she brings together the expertise of both groups. Tell us about your res

https://www.multipark.lu.se/article/neuroimmune-crosstalk-early-alzheimers-disease-phd-interview-megg-garcia-ryde - 2026-07-09

In today's scientific world, microscopic images have become a powerful resource for research. With access to advanced microscopes, researchers can now create unique images of structures and objects. Beautiful and captivating images that can also convey complex context to a wider audience. Microscopic images offer a clear advantage over purely quantitative measurements: they allow us to see the str

https://www.multipark.lu.se/article/making-invisible-visible-magic-microscopic-images - 2026-07-09

Is it possible that a single biomarker can detect all types of diseases related to dopamine deficiency in the brain? Yes, that's what a research group in Lund is discovering. "We have observed that an enzyme in cerebrospinal fluid and in blood is a useful marker for identifying all types of Parkinson's-related diseases with high accuracy," says Oskar Hansson, who led the study. The marker in quest

https://www.multipark.lu.se/article/new-blood-marker-can-identify-parkinsonian-diseases - 2026-07-09

Jana Rájová’s research turns light on gene expression in different parts of the brain affected by Parkinson’s disease. October 23, she defends her thesis in the Molecular Neuromodulation research group. In this interview, she tells about how it has been to combine wet and dry lab work and about the technical advances in the field. Tell us about your research! “Throughout my Ph.D. journey, my resea

https://www.multipark.lu.se/article/gene-expression-parkinsons-disease-phd-interview-jana-rajova - 2026-07-09

A recent publication by MultiPark researchers at Lund University’s Lund Stem Cell Center gives a closer look at the making of a novel stem cell therapy for Parkinson’s Disease, STEM-PD, which has been approved for a Phase I/IIa clinical trial in Europe. Parkinson's Disease is a neurodegenerative disorder that affects almost 8 million people worldwide, causing movement difficulties due to the loss

https://www.multipark.lu.se/article/closer-look-making-novel-stem-cell-therapy-parkinsons-disease - 2026-07-09

Sweden has made significant strategic investments into the national infrastructure MAX IV, with world-unique instruments usable across disciplines. One emerging area is within medical sciences. MultiPark researchers now gather across research groups to facilitate the usage of these state-of-the-art techniques available just around the corner. MAXIV for high-resolution, sub-cellular X-ray measureme

https://www.multipark.lu.se/article/maxiv-high-resolution-sub-cellular-x-ray-measurements-special-interest-group - 2026-07-09